Skip to main content
. 2023 Jul 11;14:1229233. doi: 10.3389/fphar.2023.1229233

FIGURE 8.

FIGURE 8

E2F1 promotes the malignant biological traits of STS cell lines. (A) Knockdown efficiency for E2F1 in hSS-005R cell lines. (B) CCK-8 assay between hSS-005R cell lines treated with E2F1 siRNA versus those treated with control siRNA. (C) Clone formation between hSS-005R cell lines treated with E2F1 siRNA versus those treated with control siRNA. (D) Scratch assay between hSS-005R cell lines treated with E2F1 siRNA versus those treated with control siRNA.